No Pharma Money
All News & Reports

News

The week in prescription drug pricing: what moved, what it means for patients, and what comes next.

Stay Up To Date

News and reports from P4ADNow

News Oct 8, 2019

NEW STATE LAW: Anticompetitive Pay-For-Delay Deals Banned in California

Patients applauded California Governor Gavin Newsom today after he signed a first-in-the-nation law that will stop Big Pharma from cutting deals that block less-expensive generic drugs for state…

Read Article
News Sep 30, 2019

The Week in Review in Prescription Drug Pricing

The drug lobby is throwing mounds of cash around in an attempt to convince lawmakers that drug pricing’s status quo should remain.

Read Article
News Sep 26, 2019

Patients to Congress: Let Medicare Negotiate

Patients hit by skyrocketing drug prices are speaking out in favor of Medicare negotiation in response to a plan in the House of Representatives that would lower drug costs for Americans through…

Read Article
News Sep 25, 2019

The cost has more than doubled.

My name is Bob Fowler. I am a North Ridgeville, Ohio resident, a soon-to-be-retired college professor, and a cancer patient.

Read Article
News Sep 23, 2019

The Week in Review in Prescription Drug Pricing

TL;DR of PhRMA’s statement on the House plan to lower drug prices? “We’re good with the high prices, thanks.”

Read Article
News Sep 23, 2019

All we want is access to our medication without having to bankrupt our family.

My name is Ruth Rinehart and I am a resident of Tampa, Florida. I am a nurse case manager and just like some of my patients, I rely on life-saving medication for my survival.

Read Article
News Sep 23, 2019

Think about when it might be you or a loved one in that hospital bed.

My name is Robert Keller. I’m a 66-year old resident of Parsippany, NJ.

Read Article
News Sep 20, 2019

These prices are devastating.

My name is Sue Lee and I’m a 77-year-old resident of Crestwood, Kentucky.

Read Article
News Sep 16, 2019

The Week in Review in Prescription Drug Pricing

A leaked draft of a House plan to empower the U.S. government to negotiate drug prices injects enthusiasm into the drug pricing debate and overlaps with President Trump’s plan. — (New York Times/FiercePharma)

Read Article
News Sep 9, 2019

The Week in Review in Prescription Drug Pricing

Pharma just took a DNA test. Turns out they’re 100% OVERPRICED.

Read Article

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.